Cargando…

Majocchi’s granuloma: current perspectives

Majocchi’s granuloma (MG) is a rare fungal infection of the dermis that is mainly caused by dermatophytes (in ≥95% of cases); the most frequently identified cause is anthropophilic Trichophyton rubrum. In the rest of the cases, the causes are non-dermatophytic fungi such as Aspergillus species. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Boral, Hazal, Durdu, Murat, Ilkit, Macit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968791/
https://www.ncbi.nlm.nih.gov/pubmed/29861637
http://dx.doi.org/10.2147/IDR.S145027
_version_ 1783325844649803776
author Boral, Hazal
Durdu, Murat
Ilkit, Macit
author_facet Boral, Hazal
Durdu, Murat
Ilkit, Macit
author_sort Boral, Hazal
collection PubMed
description Majocchi’s granuloma (MG) is a rare fungal infection of the dermis that is mainly caused by dermatophytes (in ≥95% of cases); the most frequently identified cause is anthropophilic Trichophyton rubrum. In the rest of the cases, the causes are non-dermatophytic fungi such as Aspergillus species. This review aimed to provide information about the current perspectives on MG regarding its clinical characteristics, predisposing factors, laboratory diagnosis, and treatment strategies. Although the lower extremities were reported to be the most common site of infection, facial involvement has been predominant in the past 5 years. Our literature research showed that the most common predisposing factor (55%) is the use of topical steroid creams without potassium hydroxide examination during treatment of erythematous squamous dermatoses. A reliable diagnosis of MG is based on histopathological examination, including fungal culture and molecular analyses. MG should be treated not only with topical agents but also with systemic antifungal agents that are continued until the lesions are completely resolved. In systemic treatment, the most preferred drug is terbinafine, because of its efficacy, side effects, and safety.
format Online
Article
Text
id pubmed-5968791
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59687912018-06-01 Majocchi’s granuloma: current perspectives Boral, Hazal Durdu, Murat Ilkit, Macit Infect Drug Resist Review Majocchi’s granuloma (MG) is a rare fungal infection of the dermis that is mainly caused by dermatophytes (in ≥95% of cases); the most frequently identified cause is anthropophilic Trichophyton rubrum. In the rest of the cases, the causes are non-dermatophytic fungi such as Aspergillus species. This review aimed to provide information about the current perspectives on MG regarding its clinical characteristics, predisposing factors, laboratory diagnosis, and treatment strategies. Although the lower extremities were reported to be the most common site of infection, facial involvement has been predominant in the past 5 years. Our literature research showed that the most common predisposing factor (55%) is the use of topical steroid creams without potassium hydroxide examination during treatment of erythematous squamous dermatoses. A reliable diagnosis of MG is based on histopathological examination, including fungal culture and molecular analyses. MG should be treated not only with topical agents but also with systemic antifungal agents that are continued until the lesions are completely resolved. In systemic treatment, the most preferred drug is terbinafine, because of its efficacy, side effects, and safety. Dove Medical Press 2018-05-22 /pmc/articles/PMC5968791/ /pubmed/29861637 http://dx.doi.org/10.2147/IDR.S145027 Text en © 2018 Boral et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Boral, Hazal
Durdu, Murat
Ilkit, Macit
Majocchi’s granuloma: current perspectives
title Majocchi’s granuloma: current perspectives
title_full Majocchi’s granuloma: current perspectives
title_fullStr Majocchi’s granuloma: current perspectives
title_full_unstemmed Majocchi’s granuloma: current perspectives
title_short Majocchi’s granuloma: current perspectives
title_sort majocchi’s granuloma: current perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968791/
https://www.ncbi.nlm.nih.gov/pubmed/29861637
http://dx.doi.org/10.2147/IDR.S145027
work_keys_str_mv AT boralhazal majocchisgranulomacurrentperspectives
AT durdumurat majocchisgranulomacurrentperspectives
AT ilkitmacit majocchisgranulomacurrentperspectives